Laura Norton-mason, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 36 Inverness Dr, Delran, NJ 08075 Phone: 609-304-2739 |
News Archive
Radient Pharmaceuticals Corporation today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010.
A Phase I clinical trial of SNS-032, one of the first in a new class of drugs that inhibit cyclin-dependent kinases, demonstrated the drug's safety and potential clinical action against advanced chronic lymphocytic leukemia. Cyclin-dependent kinases are enzymatic proteins that are integrally involved in cellular metabolism, renewal and signaling, and are thought to play key roles in the growth of cancers.
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week 2020.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
A new study by researchers from Children's Mercy Hospitals and Clinics in Kansas City, Mo., found that rapid electronic review of children's heart images by specialists nearly 200 miles away allowed for earlier diagnosis and treatment of potentially serious pediatric heart problems. The study was presented at the American Academy of Pediatrics National Conference and Exhibition in San Francisco.
› Verified 3 days ago